BAC numbering is according to NCBI Mapviewer annotation; http://www.ncbi.nlm.nih.gov/mapview/ i) primer location and restriction sites for tat genomic sequence analysis Int-ChrX: AflIII nt16022 primer nt16381; 5′-GAGGTAAAGAATGTCATAGCTTGTGGGC-3′ Int-Chr2: AflIII nt21827 primer nt19680; 5′-CCTGTGGAACTCTGAGCCAATAAACC-3′ HIV-1: AflIII nt6065 primer nt5600; 5′-GAGTGAAGCTGTTAGACATTTTCCTAGGATATGGCTC-3′
ii) integration site confirmation for int-ChrX and int-Chr2 (BAC position as reference) Int-ChrX: primer ChrXR nt15738-5768 5′-CAGAACTCTTCCAGCTGCTATTCAGTGCTTG-3′ Int-Chr2: primer Chr2R nt22013-21991 5′-CCTGTGGAACTCTGAGCCAATAAACC-3′ HIV-1: primer nef/U3 nt9091-9197 5′-GGGGGGACTGGAAGGGATAATTTACTCC-3′
B. Plasmid constructs and riboprobes
Note: pNL4-3 and pNL4-3.Luc.R-E-are abbreviated as pNL4 and pNL4-luc respectively i) pNL4-msd; 1µg pNL4-3 was digested with ApaI/NcoI, purified by agarose gel electrophoresis, klenow treated and relegated to produce a plasmid designated pNL4-∆A/N; 50ng was used as a template in PCR mediated site directed mutagenesis. Mutants were identified by sequencing both strands, subcloned into non-template pNL4-∆A/N using NdeI / EcoNI, then subcloned into pNL4-3 using AatII/SphI.
ii) pNL4-luc.SPA; a double stranded oligonucleotide containing a BanI site and 5′XhoI/3′NgoMIV linkers was subcloned into XhoI/NgoMIV digested pNL4-luc (forward oligonucleotide as follows; poly(A) site region underlined; BanI site in bold) and confirmed by sequencing both strands:
wild type: 5′-CTCGAGGGTACCCCGATCCAATAAAAGATCTTTATT TTCATTAGATCTGTGTGTTGGTTTTTGTGTGGGCCGGC-3′ mutant:
5′-CTCGAGGGTACCCCGATCCGCGGCGAGATCTTTATT TTCATTAGATCTGTGTGTTGGTTTTTGTGTGGGCCGGC-3′
iii) pNL4-luc.CMV was constructed by removing the FspA1/BssHII fragment of pNL4-luc (containing the HIV-1 5′LTR promoter) and replacing with a ScaI / BssHII fragment of CMVmg construct (Ashe et al., 2000) . To construct pNL4-luc.DSE, pNL4-luc was digested with AatII / BamHI, blunt ended by klenow and relegated to form pNL4-∆A/B; containing the HIV-1 3′LTR only.
iv) pNL4-luc.DSE was constructed by removing the U5 region-containing HindIII / NgoMIV fragment of pNL4-luc..∆A/B (nt9607-10350) whilst preserving the AAUAAA poly(A) hexamer by klenow-treatment. A XhoI / NcoI fragment spanning this region was then subcloned into non-template pNL4-luc.
iv) riboprobes; pNL4-wt and pNL4-msd were obtained by site directed mutagenesis of the pHmgM1riboprobe (Ashe et al., 1995; see main text) . Figure S2 
